Alexey Fayzullin | Medicine and Dentistry | Pioneer Researcher Award

Dr. Alexey Fayzullin | Medicine and Dentistry | Pioneer Researcher Award

Sechenov University, Russia

Dr. Alexey Fayzullin, PhD, MD, is a distinguished medical scientist specializing in regenerative medicine, computational pathology, and digital biomedical technologies, with a strong academic and research foundation at Sechenov University, Russia. He completed his general medical studies at the International School “Medicine of the Future” (2011–2017) and earned his PhD in anatomical pathology in 2022, with a thesis on antifibrotic scaffolds in regenerative medicine. His professional journey began as a laboratory assistant (2018–2019) and junior researcher (2019–2023) in the Laboratory of Experimental Morphology at the Institute for Regenerative Medicine, before advancing to Head of the Laboratory of Digital Microscopic Analysis in 2023. His research interests span tissue engineering, artificial intelligence in histological image analysis, cell therapy, biophotonics, implantology, and computational biomedicine. With 47 peer-reviewed publications, 626 citations, and an h-index of 12, Dr. Fayzullin has contributed significantly to scientific knowledge, with his works appearing in internationally recognized journals and conferences. His research experience includes prestigious internships at Macquarie University and the University of New South Wales, where he collaborated on advanced bioengineering projects. He has won multiple competitive grants and awards, including several Russian Presidential Scholarships for international research, grants from the Russian Science Foundation (RSF) and Russian Foundation for Basic Research (RFBR), and the establishment of his own laboratory under the Priority 2030 program. His skills include advanced digital microscopy, AI-based image processing, regenerative scaffold design, project leadership, and academic mentoring. As an educator, he has co-authored Russia’s first regenerative medicine handbook, designed specialized academic courses, and supervises PhD and undergraduate students. Dr. Fayzullin’s honors, leadership roles, and international collaborations highlight his impact on both science and education. In conclusion, his remarkable achievements, innovative research, and commitment to biomedical advancement demonstrate why he is an emerging leader with the potential to shape the future of global regenerative medicine and digital healthcare.

Profile: Scopus | ORCID | Google Scholar

Featured Publications

Valieva, Y., Ivanova, E., Fayzullin, A., Kurkov, A., & Igrunkova, A. (2022). Senescence-associated β-galactosidase detection in pathology. Diagnostics, 12(10), 2309. Cited 146 times

Shekhter, A. B., Fayzullin, A. L., Vukolova, M. N., Rudenko, T. G., Osipycheva, V. D., & Litvitsky, P. F. (2019). Medical applications of collagen and collagen-based materials. Current Medicinal Chemistry, 26(3), 506–516. Cited 129 times

Deng, W., McKelvey, K. J., Guller, A., Fayzullin, A., Campbell, J. M., Clement, S., & Saunders, C. M. (2020). Application of mitochondrially targeted nanoconstructs to neoadjuvant X-ray-induced photodynamic therapy for rectal cancer. ACS Central Science, 6(5), 715–726. Cited 88 times

Fayzullin, A., Bakulina, A., Mikaelyan, K., Shekhter, A., & Guller, A. (2021). Implantable drug delivery systems and foreign body reaction: Traversing the current clinical landscape. Bioengineering, 8(12), 205. Cited 73 times

Fayzullin, A., Churbanov, S., Ignatieva, N., Zakharkina, O., Tokarev, M., & Shekhter, A. (2021). Local delivery of pirfenidone by PLA implants modifies foreign body reaction and prevents fibrosis. Biomedicines, 9(8), 853. Cited 35

Shekhter, A. B., Pekshev, A. V., Vagapov, A. B., Telpukhov, V. I., Panyushkin, P. V., Fayzullin, A. L., & Vanin, A. F. (2019). Physicochemical parameters of NO-containing gas flow affect wound healing therapy: An experimental study. European Journal of Pharmaceutical Sciences, 128, 193–201. Cited 34

HYO-SANG PARK | Dentistry | Excellence in Research Award

Prof. HYO-SANG PARK | Dentistry | Excellence in Research Award

Department of Orthodontics, Kyungpook National Univsersity, South Korea

Prof. Hyo-Sang Park, DDS, MSD, Ph.D., is a distinguished scholar, clinician, and global leader in orthodontics, widely recognized for pioneering orthodontic microimplants that have revolutionized treatment protocols worldwide. He completed his Doctor of Dental Surgery (DDS) at Kyungpook National University in Daegu, Korea, followed by specialist orthodontic training and authorization at Kyungpook National University Hospital. He earned a Master of Science in Orthodontics and later obtained his Ph.D. in Oral Biology and Orthodontics from Kyungpook National University, reflecting a solid academic foundation. Professionally, he has served as a full-time instructor, assistant professor, and associate professor at Keimyung University Medical College before becoming Professor and Chair of the Department of Orthodontics at Kyungpook National University, while also enriching his international exposure as a Visiting Associate Professor at the University of Oklahoma, USA. His research interests include the development of orthodontic microimplants, microimplant-assisted orthodontic treatment, clear aligner-microimplant combined treatment, and orthognathic surgery. With expertise spanning biomechanics, surgical orthodontics, device design, and clinical applications, his research skills have resulted in over 114 indexed publications, 4,303 citations, and an h-index of 33, alongside multiple patents for orthodontic anchorage systems and innovative devices. His books and monographs, translated into Korean, English, Japanese, Chinese, Spanish, and Portuguese, further highlight his international influence, and his more than 200 lectures, 300 training courses, and global presentations underscore his role as a thought leader and educator. Prof. Park has received widespread recognition for his contributions, including leadership in academic societies, authorship of standard orthodontic textbooks, and patents that bridge clinical innovation with patient care. In conclusion, Prof. Hyo-Sang Park’s career reflects an exceptional blend of academic excellence, pioneering research, international collaboration, and mentorship, making him highly deserving of global recognition for his transformative contributions to orthodontics and his ongoing potential to advance the field through innovation, leadership, and education.

Profile: Scopus | ORCID | Google Scholar

Featured Publication

Park, H. S., Jeong, S. H., & Kwon, O. W. (2006). Factors affecting the clinical success of screw implants used as orthodontic anchorage. American Journal of Orthodontics and Dentofacial Orthopedics, 130(1), 18–25.  — Cited 984

Park, H. S. (2001). MIA (Micro-Implant Anchorage) for Class I bialveolar protrusion. Journal of Clinical Orthodontics, 35(7), 417–422. — Cited 803

Kyung, H. M., Park, H. S., Bae, S. M., & Jae-Hyun, S. (2003). Overview: Development of orthodontic micro-implants for intraoral anchorage. Journal of Clinical Orthodontics, 37(6), 321–328. — Cited 718

Bae, S., Park, H. S., Kyung, H. M., Kwon, O. W., & Sung, J. H. (2002). Clinical application of micro-implant anchorage. Journal of Clinical Orthodontics, 36(5), 298–302. — Cited 583

Lee, M. H., Kwon, T. G., Park, H. S., Wozney, J. M., & Ryoo, H. M. (2003). BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochemical and Biophysical Research Communications, 309(3), 689–694. Cited 561

Giovanni Musso | Medicine and Dentistry | Best Researcher Award

Giovanni Musso | Medicine and Dentistry | Best Researcher Award

AOU San Luigi Gonzaga Orbassano (Torino), Italy

Dr. Giovanni Musso is a renowned clinician and researcher in Internal Medicine with a distinguished academic and professional career. He graduated in Medicine in 1996 with top honors (110/110) and completed his specialization in Internal Medicine in 2002 with distinction. Currently serving at the Department of Internal Medicine, Humanitas Gradenigo Hospital, Turin, he has devoted his career to the study of lipid and glucose metabolism, with particular emphasis on non-alcoholic fatty liver disease (NAFLD), metabolic dysfunction-associated steatotic liver disease (MASLD/MASH), and related metabolic complications. He leads international collaborative research involving 34 centers worldwide, producing high-impact findings on NAFLD epidemiology, pathogenesis, and staging, with publications in PLOS Medicine, Hepatology, Gastroenterology, BMJ, and other leading journals. His research interests include lipidomics, postprandial metabolism, gut microbiota, metabolic inflammation, and therapeutic innovations such as curcumin-based interventions and endoscopic approaches for metabolic disorders. His research skills span clinical trials, meta-analyses, translational studies, and consensus guideline development. Recognized globally, Dr. Musso has authored 101 documents, accrued 12,017 citations, and holds an impressive h-index of 49 (Sept 2025). His honors include co-authoring international consensus statements and leading global research collaborations. With his proven excellence in research, teaching, and clinical innovation, Dr. Musso continues to advance the field of hepatology and metabolic medicine while shaping future directions in precision healthcare.

Profile: ScopusORCID

Featured Publications

  • Musso, G., Mariano, F., Mella, A., Pinach, S., & Gambino, R. (2025, August 7). Meal-Induced NF-κB Activation in Mononuclear Cells Triggers Lumican Secretion and Promotes Chronic Kidney Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease. MedComm, 6(8), e70122.

  • Carpenito, N., Leporati, M., Sciarrillo, A., Pensa, A., Gambino, R., Musso, G., Mella, A., Biancone, L., Risso, D., Mariano, F., & Cosseddu, D. (2025, May 16). LC-MS/MS Determination of Quorum Sensing Molecules in Plasma from Burn Patients with Septic Shock Sustained by Acinetobacter baumannii. Antibiotics (Basel), 14(5), 517.

  • Musso, G., Mella, A., Mariano, F., Cassader, M., De Michieli, F., Riva, A., Petrangolini, G., Togni, S., Pinach, S., & Gambino, R. (2024). Impaired Postprandial GLP-2 Response Enhances Endotoxemia, Systemic Inflammation, and Kidney Injury in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Effect of Phospholipid Curcumin Meriva. Gut Microbes, 16(1), article 2424907.

  • Musso, G., Pinach, S., Mariano, F., Saba, F., De Michieli, F., Framarin, L., Berrutti, M., Paschetta, E., Parente, R., Lizet Castillo, Y., Leone, N., Castellino, F., Cassader, M., & Gambino, R. (2025, February 1). Effect of Phospholipid Curcumin Meriva® on Liver Histology and Kidney Disease in Nonalcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial. Hepatology, 81(2), 560–575.

  • Musso, G., Pinach, S., Saba, F., De Michieli, F., Cassader, M., & Gambino, R. (2024, July). Endoscopic Duodenal Mucosa Ablation Techniques for Diabetes and Nonalcoholic Fatty Liver Disease